E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic…
Study links gut dysbiosis with severe steatosis in MASLD
A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a…